Saba Capital Management’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Saba Capital Management’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-368,429	Closed	-$3.68M	–	1018
2022 Q3	$3.68M	Hold	368,429	–	–	0.04%	572
2022 Q2	$3.63M	Buy	368,429 +13,586	+4%	+$134K	0.04%	583
2022 Q1	$3.49M	Buy	354,843 +121,871	+52%	+$1.2M	0.05%	499
2021 Q4	$2.27M	Buy	232,972 +10,693	+5%	+$105K	0.03%	509
2021 Q3	$2.18M	Hold	222,279	–	–	0.05%	356
2021 Q2	$2.15M	Buy	222,279 +72,579	+48%	+$707K	0.06%	278
2021 Q1	$1.45M	Buy	+149,700	New	+$1.45M	0.05%	267

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Saba Capital Management's PKBO Position: Q4 2022 in Review

Saba Capital Management sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 368,429 shares — an estimated $3.68M sold.

Saba Capital Management first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $3.68M in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Saba Capital Management reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Saba Capital Management sold 368,429 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $3.68M.
Saba Capital Management first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Saba Capital Management's Peak Bio, Inc. Common Stock position peaked at $3.68M in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Saba Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.